ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea
· Delayed Price · Currency is KRW 1,024.00
+4.00 (0.39%)
At close: Jun 27, 2025, 3:30 PM KST
KOSDAQ:034940 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -10,129 | -9,605 | -10,514 | 560.69 | -8,044 | -1,319 | Upgrade
|
| Depreciation & Amortization | 2,273 | 2,389 | 2,387 | 2,388 | 2,893 | 3,050 | Upgrade
|
| Loss (Gain) From Sale of Assets | -293.83 | -293.83 | -85.73 | - | -8.72 | -3.77 | Upgrade
|
| Asset Writedown & Restructuring Costs | 246.28 | 246.28 | 1,989 | 107.1 | 1,938 | 946.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | 54.99 | 2.95 | -171.99 | -235.85 | -1,605 | -737.7 | Upgrade
|
| Loss (Gain) on Equity Investments | -22.8 | -14.78 | -19.87 | 4.83 | -17.96 | -11.2 | Upgrade
|
| Provision & Write-off of Bad Debts | 587.92 | 504.79 | 202.2 | -230.01 | 269.87 | 109.57 | Upgrade
|
| Other Operating Activities | 2,797 | 2,666 | 4,384 | 1,864 | 3,899 | 2,809 | Upgrade
|
| Change in Accounts Receivable | 804.08 | 1,543 | 2,287 | -2,644 | 400.47 | 2,363 | Upgrade
|
| Change in Inventory | 1,154 | 596.73 | -2,212 | -549.25 | 2,292 | -3,455 | Upgrade
|
| Change in Accounts Payable | -1,279 | -646.98 | 507.62 | 1,304 | 81.5 | 79.75 | Upgrade
|
| Change in Other Net Operating Assets | -1,392 | -1,856 | -228.1 | -4,012 | -3,580 | -1,909 | Upgrade
|
| Operating Cash Flow | -5,199 | -4,468 | -1,475 | -1,443 | -1,480 | 1,922 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | -53.77% | Upgrade
|
| Capital Expenditures | -595.46 | -551.31 | -831.13 | -2,782 | -3,544 | -3,598 | Upgrade
|
| Sale of Property, Plant & Equipment | 481.47 | 481.47 | 128.61 | - | 14.55 | 3.77 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -359.58 | Upgrade
|
| Sale (Purchase) of Intangibles | -295.07 | -229.11 | -111.52 | -140.19 | -319.99 | -42.39 | Upgrade
|
| Investment in Securities | 42.62 | -1,159 | 1,944 | 1,479 | 1,566 | 29.79 | Upgrade
|
| Other Investing Activities | -234.75 | -343.71 | -398.94 | -110.22 | 417.53 | -70.15 | Upgrade
|
| Investing Cash Flow | -601.19 | -1,802 | 731.38 | -1,553 | -1,866 | -4,037 | Upgrade
|
| Long-Term Debt Issued | - | 9,630 | 15,349 | 7,658 | 9,344 | 1,000 | Upgrade
|
| Long-Term Debt Repaid | - | -3,406 | -17,012 | -5,863 | -4,621 | -4,664 | Upgrade
|
| Net Debt Issued (Repaid) | 852.21 | 6,224 | -1,662 | 1,795 | 4,723 | -3,664 | Upgrade
|
| Other Financing Activities | -78 | -32 | -27.22 | 11.51 | 101.29 | -168.02 | Upgrade
|
| Financing Cash Flow | 774.21 | 6,192 | -1,690 | 1,807 | 4,825 | -3,832 | Upgrade
|
| Foreign Exchange Rate Adjustments | 70.41 | 127.94 | -44.95 | -33.84 | 106.45 | 73.71 | Upgrade
|
| Net Cash Flow | -4,955 | 50.04 | -2,478 | -1,223 | 1,585 | -5,873 | Upgrade
|
| Free Cash Flow | -5,794 | -5,019 | -2,306 | -4,225 | -5,024 | -1,677 | Upgrade
|
| Free Cash Flow Margin | -9.36% | -8.01% | -3.66% | -6.13% | -8.73% | -2.56% | Upgrade
|
| Free Cash Flow Per Share | -187.35 | -162.02 | -74.45 | -136.37 | -162.17 | -54.12 | Upgrade
|
| Cash Interest Paid | 1,055 | 1,026 | 913.95 | 564.55 | 287.07 | 203.18 | Upgrade
|
| Cash Income Tax Paid | 10.23 | 14.42 | -10.98 | -45.22 | - | 46.92 | Upgrade
|
| Levered Free Cash Flow | -1,438 | -894.16 | -850.27 | -3,337 | -3,096 | -1,623 | Upgrade
|
| Unlevered Free Cash Flow | -726.59 | -197.11 | -238.19 | -2,914 | -2,861 | -1,241 | Upgrade
|
| Change in Net Working Capital | -4,264 | -4,337 | -3,813 | 2,079 | -2,486 | -509.54 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.